Resveratrol: why is it a promising therapy for chronic kidney disease patients?
about
Correlation between oxidative stress and the NF-κB signaling pathway in the pulmonary tissues of obese asthmatic mice.Dual effect of red wine on liver redox status: a concise and mechanistic review.Recent Progress in Therapeutics for Inflammation-Associated Preterm Birth: A Review.Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation.Resveratrol alleviates the cytotoxicity induced by the radiocontrast agent, ioxitalamate, by reducing the production of reactive oxygen species in HK-2 human renal proximal tubule epithelial cells in vitroHSP90 inhibitor 17-DMAG exerts anticancer effects against gastric cancer cells principally by altering oxidant-antioxidant balance.Mir-217 promotes inflammation and fibrosis in high glucose cultured rat glomerular mesangial cells via Sirt1/HIF-1α signaling pathway.Resveratrol treatment restores peripheral insulin sensitivity in diabetic mice in a sirt1-independent manner.Effect of resveratrol on progression of polycystic kidney disease: a case of cautious optimism.Mediterranean diet as the diet of choice for patients with chronic kidney disease.Oxidative Stress in Kidney Diseases: The Cause or the Consequence?Resveratrol: from diet to topical usage.Resveratrol Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis through C3aR/C5aR- Sphingosine Kinase 1 Pathway.
P2860
Q36520199-E7411633-A0B1-47B2-8B78-34E7548A2A00Q38508760-7E8B0698-22DC-470D-8706-DB6E0B593C08Q38655581-07202A1C-C8EF-40F3-8C32-680B7D91773CQ38800191-841BBE29-FD33-44DD-B212-13AA0E6580E7Q38819221-15CA8054-73A7-41C9-89CC-88838970A2D3Q41346196-8E9DF081-048C-429B-90FD-12215C234FACQ42699497-463AFAD2-65BE-48F1-8118-5DF00F476D04Q42702186-54D89634-469B-492D-8CE4-5E114A7730ADQ46740695-5440FEF9-68AF-4355-AA06-910D765427FCQ47437800-9D6737C6-8B9E-47AC-A958-50EB24C9F856Q48163520-45BA19FC-45AB-440E-B672-E86A1140DB3AQ50072963-101C3D03-04DD-4727-A557-691F8428FB4BQ54151193-3458B1E8-99C0-4B77-ACAB-AAFD7BC9C2C6
P2860
Resveratrol: why is it a promising therapy for chronic kidney disease patients?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Resveratrol: why is it a promising therapy for chronic kidney disease patients?
@en
Resveratrol: why is it a promising therapy for chronic kidney disease patients?
@nl
type
label
Resveratrol: why is it a promising therapy for chronic kidney disease patients?
@en
Resveratrol: why is it a promising therapy for chronic kidney disease patients?
@nl
prefLabel
Resveratrol: why is it a promising therapy for chronic kidney disease patients?
@en
Resveratrol: why is it a promising therapy for chronic kidney disease patients?
@nl
P2093
P2860
P356
P1476
Resveratrol: why is it a promising therapy for chronic kidney disease patients?
@en
P2093
José Carlos Carraro-Eduardo
Juliana F Saldanha
Viviane de O Leal
P2860
P304
P356
10.1155/2013/963217
P5008
P577
2013-12-29T00:00:00Z